Inovio Clinical Trials: Cancer

Inovio Biomedical or its partners/collaborators are conducting the following ongoing clinical trials for the treatment of cancers. Patients are being recruited for these trials, with details available by following the links below.

Indications: Human papillomavirus (HPV)/Cervical cancer

Treatment: VGX-3100

Study title: Phase I Open Label, Dose Escalation Study to Evaluate the Safety, Tolerability and Immunogenicity of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation (EP) in Adult Females Post Surgical or Ablative Treatment of Grade 2 or 3 Cervical Intraepithelial Neoplasia (CIN)

Trial Stage: Phase I

http://www.clinicaltrials.gov/ct2/show/NCT00685412?term=vgx&rank=1

Indications: Breast, lung, prostate & other cancers

Treatment: V934/V935

Study title: A Phase I Investigation of the Safety, Tolerability and Immunogenicity of V934/V935 hTERT Vaccination in Cancer Patients With Selected Solid Tumors

Trial Stage: Phase I